© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Eltrombopag Olamine stands out as a small-molecule compound that plays a vital role in the management of low platelet counts, particularly for patients dealing with chronic immune thrombocytopenia and other related blood disorders. This synthetic molecule belongs to the class of thrombopoietin receptor agonists. Chemically, it carries the molecular formula C29H34N6O6•C2H7NO, and it has a molar mass hovering around 564 g/mol, adding the Olamine moiety. Coverage of its structure reveals a complex arrangement of aromatic rings and heterocycles, which underpin its selectivity and activity at the cell receptor level. Many people battling with chronic blood conditions rely on access to this substance, not just for its therapeutic role but also for maintaining quality of life. As someone familiar with the need for accurate chemical information—in both medical and scientific settings—I know how confusion or inaccuracy can create real problems for users and providers alike, making straightforward communication about it essential.
Eltrombopag Olamine comes as a solid, most commonly found in the form of crystals, flakes, or powder. The compound shows off a pale-yellow to beige color in its pure state. Manufacturers take pride in achieving high purity standards—often above 99%—because tiny impurities can alter its efficacy or introduce safety questions. Specific gravity rests at about 1.4 g/cm3, and the compound typically melts in the range of 200 to 220°C, reflecting the stability of its molecular framework. This powder resists dissolution in water, but dissolves reliably in dimethyl sulfoxide, ethanol, or methanol. Any professional using this material in the lab or during production needs to keep its solubility profile in mind, since improper solvent use not only wastes resources but can lead to failed reactions or flawed products. I’ve worked with substances that were poorly described or mislabeled—this wastes time and creates stress for everyone trying to get a job done right.
The chemical skeleton of Eltrombopag Olamine consists of interconnected aromatic rings, nitrogen atoms embedded in heterocyclic structures, and multiple functional groups that contribute to potency and stability. Each piece of the molecule was engineered to survive stomach acid, slip into the bloodstream, and then go to work at the thrombopoietin receptor. Density measurements, taken directly by lab equipment, give about 1.4 g/cm3, but anyone working with bulk material should check their supplier’s certificate of analysis because variation can affect process design. The solid form gives the most stable shelf life—fluctuation in humidity or poor storage can cause clumping, loss of powdery consistency, and even mild degradation. R&D chemists often insist on granular or “pearl” forms because these handle well during weighing and mixing, minimizing loss through dust or electrostatic cling—a lesson learned after more than a few clumpy samples slowed down critical research projects.
The global movement and sale of Eltrombopag Olamine depends on precise specifications. Shipping samples or large commercial batches requires referencing the correct Harmonized System (HS) Code, which for this compound falls under 2933.99, marking it as part of the nitrogen-function compounds used in pharmaceutical production. Relying on the HS Code gives everyone in the supply chain—from customs inspectors to warehouse staff—a standardized label, smoothing transit and customs processes. In practice, missing or wrong codes can idle vital medicines for weeks, a delay I’ve seen firsthand during complex import transactions where paperwork mix-ups blocked delivery, hurting both suppliers and end users.
People in labs or factories must treat Eltrombopag Olamine with respect for its physiological activity. Dust and fine powders can irritate the eyes and mucous membranes, so gloves, goggles, and dust masks count as standard kit in any workplace. On risk assessment charts, it registers as harmful because large exposures or improper use can damage organs or affect blood chemistry. Material safety data sheets outline accident procedures: spills require prompt sweeping with anti-static tools, and containers need clear labeling to avoid accidental cross-contamination. Storage happens in cool, dry spaces, shielded from light and incompatible chemicals. From personal experience dealing with research chemicals, I know that sloppiness—casual handling, weak labeling, or ignoring expiration dates—carries real costs, including wasted budgets and safety hazards for everyone down the line.
Sourcing of pharmaceutical raw materials, including Eltrombopag Olamine, leans on chemical plants capable of producing complex intermediates with traceable purity. As with most synthetic molecules, the chain starts with smaller organic acids, bases, and solvents—each with their own safety and waste guidelines. Responsible producers track every ingredient, from the benzene derivatives up to the final synthesis, in compliance with local rules for health, safety, and environmental impact. Oversight from national agencies and pharmaceutical regulators aims to keep toxic by-products out of waterways and air. For organizations looking to stand out, clean manufacturing processes do more than meet legal requirements; they build trust with healthcare partners who increasingly demand science-backed transparency. Scarcity of certain precursor chemicals or regional disruptions—think port closures, geopolitical tension, or export bans—can ripple through the supply chain, reinforcing the value of reliable partnerships and diversified material sources.
Accurate, thorough information about substances like Eltrombopag Olamine doesn’t just help chemists, doctors, or logistics teams. It matters for patients depending on timely treatment, for health systems managing costs, and for investors underwriting the risks and rewards of new pharmaceuticals. For me, having spent years tracking down trustworthy sources for scientific reference and technical work, it’s become clear that technology and transparent communication can ease pain points—from shortening delivery timeframes to minimizing adverse events tied to mishandling or error. Too often, miscommunication keeps a lifesaving drug locked in a warehouse or delayed at customs, pushing up costs and eroding public confidence. Clear labeling, access to real data, and ongoing information updates set the stage for safer, more reliable medicine and research.
